White Papers / Tech Papers

How Recipharm Supported the First Lyophilized mRNA Vaccine to Pivotal Trial

Recipharm’s technology transfer and manufacturing services helped Arcturus meet its supply needs for its Phase III trial by lyophilizing ARCT-154.

Company Logo

Released By Recipharm

Request more information from Recipharm

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters